A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers

European Journal of Clinical Pharmacology

Volumn 50, Issue 1-2, 1996, Pages 57-62

  Anderson, P J ^a   Critchley, J A J H ^a   Tomlinson, B ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ACE inhibitor; Caucasians; Chinese; cilazaprilat; Cilazapril; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN;

ADULT; ARTICLE; BLOOD PRESSURE; CAUCASIAN; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG ELIMINATION; ETHNIC DIFFERENCE; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; VOLUNTEER; ASIAN; BLOOD; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; RACE; REGRESSION ANALYSIS;

ADULT; ALDOSTERONE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CILAZAPRIL; CONTINENTAL POPULATION GROUPS; ELECTROCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; REGRESSION ANALYSIS; RENIN;

EID: 0029666081     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050069     Document Type: Article

References (24)

1. Venter CP, Joubert PH (1984) Ethnic differences in response to beta 1-adrenoceptor blockade by propranolol. J Cardiovasc Pharmacol 6: 361-364
2. Zhou HH, Koshakji RP, Silberstein DJ, Wilkinson GR, Wood AJJ (1989) Racial differences in drug response: altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American Whites. N Eng J Med 320: 565-570
3. Seedat YK, Parag KB (1987) A comparison of lisinopril and atenolol in black and Indian patients with mild-to-moderate essential hypertension. S African an Med J 71:149-153
4. Chan JCN, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R (1992) Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. Br Med J 305: 981-985
5. Chan WK, Chan TYK, Luk WK, Leung VKS, Li TH, Critchley JAJH (1993) A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol 44: 299-300
6. Lee EJD (1994) Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol 37: 212-214
7. Ryan RW, Chung A, Ammons C, Carlton ML (1977) A simple radioassay for angiotensin converting enzyme. Biochem J 167: 501-504
8. Cushman CW, Cheung HS (1983) Spectrometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem Pharmacol 20:1648
9. Chen DS, Brunner HR, Waeber B (1984) In vitro response of plasma angiotensin consorting enzyme precursors and active forms of converting enzyme inhibitors. Curr Ther Res 35: 253-262
10. Nussberger J, Waeber B, Brunner HR, Burris JF, Vetter W (1984) Highly sensitive microassay for aldosterone in unextracted plasma: comparison with two other methods. J Lab Clin Med 104:789-796
11. Nussberger J, Fasanella d'Amore T, Porchet M, Waeber B, Brunner DB, Brunner HR, Kler L, Brown AN, Francis RJ (1987) Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J Cardiovasc Pharmacol 9:39-44
12. Francis RJ, Brown AN, Kler L, d'Amore TF, Nussberger J, Waeber B, Brunner HR (1987) Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model. J Cardiovasc Pharmacol 9:32-38
13. Williams PEO, Brown AN, Rajaguru S, Francis RJ, Walters GE, McEwen J, Durnin C (1989) The pharmacokinetics and bioavailability of cilazapril in normal man. Br J Clin Pharmacol 27:181S-188S
14. Elliott HL, Ajayi AA, Reid JL (1989) The influence of cilazapril on indices of autonomic function in normotensives and hypertensives. Br J Clin Pharmacol 27:303S-307S
15. Fasanella d'Amore T, Bussien JP, Nussberger J, Waeber B, Turini GA, Brunner HR, Kler L, Francis RJ (1987) Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers. J Cardiovasc Pharmacol 9:26-31
16. Anderson PJ, Critchley JAJH, Tomlinson B, Resplandy G (1995) Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers. Br J Clin Pharmacol 39:361-368
17. Chen J, Gao J (1993) The Chinese total diet study in 1990 Part II. Nutrients. Journal of AOAC International 76: 1206-1213
18. Chan TYK, Chan AYW, Lau JTF, Critchley JAJH. Sodium and potassium intake and blood pressure in an urban Chinese population in Hong Kong (unpublished data)
19. Woo J, Lau E, Chan A, Cockram C, Swaminathan R (1992) Blood pressure and urinary cations in a Chinese population. J Hum Hypertens 6:299-304
20. Liu LS, Xie JX, Fang WQ (1988) Urinary cations and blood pressure: a collaborative study of 16 districts in China. J Hypertens 6 [Suppl 4]: S587-590
21. Nara Y, Zhao GS, Huang ZD, Li YH, Mizushima S, Mano M, Zhang HX, Sun SF, Sato T, Horie R, Zhang MX, He BS, Mori C, Hatano S, Liu LS, Yamori Y (1990) Relationship between dietary factors and blood pressure in China. J Cardiovasc Pharmacol 16 [Suppl. 8]: S40-S42
22. Giudicelli JF, Richer C, Richard C, Thuillez C (1991) Angiotensin converting enzyme inhibition: systemic and regional hemodynamics in rats and humans. Am J Hypertens 4 (No. 3, Part 2):258S-262S
23. Lees KR, Reid JL (1987) The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients. Eur J Clin Pharmacol 31:519-524
24. Webster J (1987) Angiotensin converting enzyme inhibitors in the clinic: first-dose hypotension. J Hypertens 5:S27-30